# CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma

> **NCT07280793** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Xuzhou Medical University** · enrollment: 10 (estimated)

## Conditions studied

- Non-invasive CAR-T Cell Monitoring
- BCMA-targeted PET Imaging
- CAR-T Cell Biodistribution and Persistence
- GMP-compliant Radiopharmaceutical Preparation

## Interventions

- **OTHER:** BCMA-Targeting CAR-T Cell Therapy
- **DEVICE:** PET/CT Imaging

## Key facts

- **NCT ID:** NCT07280793
- **Lead sponsor:** Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07280793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07280793, "CAR-T Cell Efficacy With Molecular Imaging in Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07280793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*